Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

November’s top stories: Patheon to buy API facility, UK NICE approved Celgene’s drug

Pomalidomide is specifically approved for patients who have received at least two prior treatments, including Velcade and Revlimid. Photo: courtesy of Myeloma UK.